Disrupting the Status Quo in Clinical Trials

NYC Health Business Leaders > Disrupting the Status Quo in Clinical Trials
 

Sponsors & Hosts

09/27/2017

5:30 to 8:00 pm

Non-member price: $60
Member price: $25

Learn more about membership and join today..

PulsePoint
360 Madison Ave, 14th Floor

How payers, patients, and data are shaping the future of clinical trials

Clinical trials are changing—and changing rapidly. From greater patient involvement, integration of cost-effectiveness considerations in trial design, increasing pressure to make drug available faster, and inclusion of new sources of data, there are new opportunities to collect, curate, and integrate more data and new sensibilities. But, these new opportunities also represent new challenges for supporting clinical trials in general—integrity of new data, relevance of new sources, applicability, noise versus signal, and the overall challenges of managing a greater variety of data in a complex environment.

Join us for a panel of clinical trial, data, and technology leaders for a lively discussion on how patients, payers, and new data are changing the clinical trial enterprise.

Speakers

Yu-Feng Yvonne Chan, MD, PhD, FACEP

Director, Center for Digital Health - Icahn Institute at Mount Sinai
read bio

Emmanuel "Manny" Fombu, MD,MBA

Medical Director, US Medical Affairs and Clinical Development - Novartis
read bio

Kenneth Getz

Associate Professor and Director - CSDD, Tufts University, Founder and Board Chair - CISCRP
read bio

Erik Schulz

Chief Strategy Officer - Medidata Solutions
read bio

Dr. Manfred Stapff

Chief Medical Officer - TriNetX
read bio

Yin Ho, MD, MBA

Founder & CEO - Context Matters (MODERATOR)
read bio